- 专利标题： TL1A PATIENT SELECTION METHODS, SYSTEMS, AND DEVICES
-
申请号： US18168519申请日： 2023-02-13
-
公开(公告)号： US20230272061A1公开(公告)日： 2023-08-31
- 发明人: Laurens KRUIDENIER , Mahyar SABRIPOUR , Janine BILSBOROUGH , Dermot P. MCGOVERN , Dalin LI
- 申请人： PROMETHEUS BIOSCIENCES, INC. , CEDARS-SINAI MEDICAL CENTER
- 申请人地址： US CA San Diego
- 专利权人： PROMETHEUS BIOSCIENCES, INC.,CEDARS-SINAI MEDICAL CENTER
- 当前专利权人： PROMETHEUS BIOSCIENCES, INC.,CEDARS-SINAI MEDICAL CENTER
- 当前专利权人地址： US CA San Diego
- 主分类号： C07K16/24
- IPC分类号： C07K16/24 ; A61P1/04 ; C12Q1/6883 ; A61P1/00 ; C07K16/28
摘要：
Provided are methods, systems, and kits for selecting a patient for treatment with a therapeutic agent based on a presence of a genotype associated with a positive therapeutic response to the therapeutic agent. The therapeutic agent, in some embodiments, is an inhibitor of TL1A activity or expression, such as for example, an anti-TL1A antibody.
信息查询
